[Treatment of hepatic and intra-abdominal hydatidosis with mebendazole: prospective comparison of the cyclic and the continuous regimen].
To communicate the results of two different schedules (cyclic and continuous) of mebendazole therapy for hepatic and intraabdominal hydatid disease. Prospective and randomized. 26 cases of abdominal hydatid disease. No significant differences were registered between both groups. Cyclic mebendazole therapy does not improve the results of continuous treatment in abdominal hydatid disease.